The fluid is surrounded by a cyst wall of 3 layers, the inner germinal layer which in turn is enclosed by an acellular laminated layer and surrounded by a fibrous outer layer (referred to as either the adventitial layer or pericyst) which is of host origin. [4] [5] [6] [7] The host-parasite relationship in cystic echinococcosis is extremely complex and cyst survival, growth and development are dependent on a balance between host immunological activity from one side, and the expression of parasite immunoevasive strategies from the other. 5, [8] [9] [10] The fibrotic host response around the cyst is part of this relationship and the relative thickness of this layer can vary depending on the anatomical location of the cyst. In general, within animal hosts, it is most developed in hepatic cysts and to a lesser extent in lung cysts. [11] [12] [13] It has also been suggested that this fibrotic activity may help in restricting growth of the cysts with lung cysts being perceived as having a higher growth rate than hepatic cysts. 13 This suggestion is also supported in rare cases of brain cysts
Summary
Cystic echinococcosis is characterized by fluid-filled hydatid cysts in the liver and lungs. The cysts are surrounded by a host fibrous layer (the pericyst) which acts to isolate the parasite from surrounding tissues. Previous studies in liver cysts have indicated that the parasite may be a stimulating fibrosis. The aim of this study was to investigate whether hydatid cyst fluid (HCF) could influence the potential for fibrosis to occur in lung tissue by stimulating epithelial to mesenchymal transition (EMT) in a human lung epithelial cell line. An adenocarcinoma-derived alveolar basal epithelial cell line (A549) was used as a model for human alveolar epithelial cells (AEC II). These were cultured in vitro with HCF (UK sheep origin). Assays to investigate cell proliferation, cell migration and expression of cytoskeletal markers showed that HCF could stimulate changes indicative of EMT, including enhanced cell proliferation and migration; increased expression of mesenchymal cytoskeletal markers (fibronectin and vimentin) accompanied by a down-regulation of an epithelial marker (E-cadherin).
Molecules within hydatid cyst fluid are capable of inducing phenotypic changes in A549 cells indicating that the parasite has the potential to modify lung epithelial cells which could contribute to fibrotic reactions.
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A549 cell, echinococcosis, epithelial-mesenchymal transition, fibrosis, hydatid cyst, pulmonary where there is little fibrosis and where very high growth rates have been estimated. 14 Whilst the fibrous pericyst is clearly a mechanism by which the host is attempting to isolate the parasite and restrict its development, it could also conceivably be a mechanism which is protective to the parasite, acting as a further barrier to potentially damaging immune effector mechanisms. 15, 16 In hepatic echinococcosis (CE and AE), the parasites are known to both up-regulate and down-regulate several hundred host genes associated with metabolism, the immune system (complement cascade and antigen processing) and cell signalling and transport. [17] [18] [19] [20] and it has recently been shown that HCF from E. granulosus may promote fibrosis in hepatic stellate cells by down-regulation of miR-
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| MATERIAL S AND ME THODS

| HCF samples
Samples of HCF were obtained from fertile cysts in individual naturally infected sheep from UK abattoirs. All samples were filter sterilized and stored frozen at −20°C until use. The condition of each batch of cyst fluid was assessed by checking the relative antigenicity of samples from different sheep by ELISA against sera from human CE cases and the 6 highest reacting samples were pooled together for use in the cell culture experiments (data not shown). The protein concentration of the pooled HCF sample was estimated using a colourimetric assay (Biorad) to be 0.18 mg/mL. All samples were checked to be free from the presence of bacterial endotoxins using the ToxinSensorTM Chromogenic LAL Endotoxin Assay Kit (GenScript). Briefly, wells were washed 2 times with PBS and stained with 1 mL 0.1% crystal violet (CV) for 15 minutes at room temperature. The stain solution was aspirated and wells washed 3 times with dH 2 O before being allowed to air dry. 1 mL of methanol was then added to each well to extract the dye taken up by living cells. After 15 minutes, 100 μL was transferred to a 96-well microtitre plate and absorbance was measured at 620 nm in an Ascent Multiscan reader (Thermo Scientific). A calibration curve was used to relate optical density to estimate cell number.
| Cell proliferation assay
| Cell migration assay
Cell migration was assessed using a wound healing assay according to Liang et al 34 with minor modifications. Cells were cultured in CM as described above until 70% confluent, then washed in LSM before a longitudinal scratch (wound) was made in the middle of each well using a 100 μL pipette tip. HCF (18 μg/mL) in LSM, or LSM alone was applied as a treatment. Cells were examined after 24 and 48 hours on an inverted microscope and the distance between the 2 sides of wound was measured at 5 equidistant points along the wound (0.6 mm between each point).
| EMT
To investigate the expression of EMT markers, sub-confluent A549 cells were treated with either 10% HCF (final protein concentration = 0.18 mg/mL) in LSM, or with 5 ng/mL TGF-β1
(PeproTech-USA) in LSM, as a known inducer of EMT, 35 or LSM alone. Cells were cultured for further 3 days before immunocytochemistry and microscopic examination. Cells were washed 2 times in PBS, fixed for 5 minutes with 4% formaldehyde (SigmaAldrich), washed 2 times in PBS, then permeabilized by 1% Triton X-100 (Sigma-Aldrich) for 5 minutes (for E-cadherin) and 0.5% Triton X-100 for 10 minutes (cytokeratin, fibronectin and vimen- 
| Statistical analyses
| RE SULTS
| Cell proliferation
There were no significant differences in proliferation between HCFtreated cells and controls over the first 72 hours. However, from 3 to 5 days of culture, there was a dose-dependent increase in proliferation observed with HCF ( Figure 1 ) compared to controls (P < .001)
with the highest concentration of HCF resulting in a 250% increase in cell number.
| Cell migration
Semi-quantitative analysis of scratch assay plates showed an enhanced cell migration in the presence of HCF compared to control.
At 24 hours, HCF-treated cells (Figure 2A ) had migrated further into the "scratch" than control cells in some areas but the mean gap between each side of the "scratch" was not significantly different from controls ( Figure 2B , P > .05). However, at 48 hours, the gap between the sides of the wound was closed in many areas of the HCF-treated cells and the mean gap was significantly smaller compared to controls ( Figure 2B , P < .05). as a known EMT inducer, completely inhibited the expression of E-Cad ( Figure 3A) . Cytokeratin was ubiquitously expressed and there were no significant differences between treated and control cultures ( Figure 3B ).
| EMT
| Epithelial markers
With respect to the intracellular distribution of expression, the "extensive" pattern is more typical of an epithelial phenotype and although HCF-treated cultures appeared to demonstrate fewer cells with this distribution pattern. The differences in numbers did not reach significance, compared to those found in the control cultures (P > .05). It was also noted that the staining intensity of the HCF-treated cells was less than controls but this was not quantified. TGF-β1 also did not reduce cytokeratin expression and had a similar pattern of staining to controls.
| Mesenchymal markers
Cells treated with HCF showed up-regulation of fibronectin all treatments and all markers were compared, significant differences were evident (P < .01). The ANOVA comparing HCF-treated cells to controls for all markers showed significant differences (P < .05), but the differences between HCF-treated cells and TGF-β1-treated cells were also significant (p < .05).
| D ISCUSS I ON
The 38 to altering accessory cell function and antigen processing. 39 It has also been shown to modify the phenotype of cells such as monocytes. 40 In most cases, these effects are generally believed to influence the nature of the immune response in favour of parasite survival and often linked to a more permissive Th2 type response. It may be argued that the concentration of HCF used in these studies (18 μg/mL) is in excess of the true in vivo situation. HCF does leak out in large amounts, of cysts which have been damaged and may lead to anaphylactic reactions. 42 However, there are no definitive studies which have looked at release of cyst fluid from intact cysts. But it is known that antibodies to major cyst fluid antigens are present in most CE patients and that antibody levels may fluctuate within individuals indicating periodic release of antigen. Circulating cyst fluid antigens are also detectable in some CE patients. 43 It should also be noted that HCF is a complex mixture of both host and parasite molecules and that the total protein concentration used in these studies will reflect all molecules present. The active molecules responsible for the observed effects are therefore likely to be present in much smaller concentrations.
In the current study, it is evident that there is a mechanism by which cyst fluid components derived from lung hydatid cysts could also promote fibrosis via EMT of AECII cells and subsequent differentiation into myofibroblasts. Such events would suggest that fibrosis is potentially beneficial for the parasite by actively stimulating the building of fibrous layers. The parasite recruits host cells to migrate towards the parasite lesion and stimulates their proliferation and transition to the fibroblast-like phenotype which subsequently deposits ECM components.
The exact molecules involved in transitional events are not known. It is valid to question whether or not host components may be responsible for the observed cellular changes in A549 cells, but it is important to remember that the cell line is of human origin whilst the HCF will contain host molecules which are of sheep origin. In addition, proteomic analysis of HCF has not shown the presence of known cytokines. 2, 44 Additional studies also indicate that HCF is not simply acting as a source of nutritional protein as the same proliferative effects were not evident when HCF was substituted with bovine serum albumen (BSA) at the same concentration (See Figure S3) .
The mechanism by which HCF induces EMT is also not known. be possible but initiation of autocrine secretion of TGF-β may also be possible. With Echinococcus multilocularis infections in mice, chronic hepatic fibrosis is a classical feature of the infection and acts to both isolate the parasite and contributes to pathology.
TGF-β/Smad interactions are thought to be the driving mechanism of this process in hepatic cells, with TGF-β being produced as a result of either parasite-induced inflammation or potentially by parasite-derived molecules which can interact with the TβRI or TβRII receptor. 19 It is known that HCF contains many parasite molecules, some of which have cytokine-like properties, but it is interesting to note that the proliferative and migratory responses observed in this study were retained after heating the cyst fluid to 95°C for 5 minutes, a process that would affect the structural integrity of typical mammalian cytokines. Similar activity was also evident in a semi-purified extract of Antigen B indicating that this known, heat-stable immunomodulatory molecule may have a role (see Figures S4 and S5 ).
Extensive fibrosis and pericyst formation in CE are often seen as a mechanism by which the host restricts the growth and proliferation of the metacestode. Conversely, recent studies in experimental mice have shown that IL-17A can reduce fibrosis which leads to a reduced parasite biomass, 45 indicating that a fibrotic reaction is favourable to the parasite. The thick pericyst, in addition to acting as a barrier, 
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